| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2811 |
| Trial ID | NCT05077527 |
| Disease | Non-Hodgkin's Lymphoma | Follicular Lymphoma | B-Cell Lymphoma | Primary Mediastinal B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma | Relapsed/Refractory Diffuse Large B-Cell Lymphoma | HIV Infection |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | YesCAR-Ta|Axicabtagene Ciloleucel|axi-cel |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma |
| Year | 2021 |
| Country | United States |
| Company sponsor | AIDS Malignancy Consortium |
| Other ID(s) | AMC-112|NCI-2021-02771|AMC-112|AMC-112|UM1CA121947 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||